INVE Technologies Offers to Buy Back Up to $20 Million of Its Stock at $2.85–$3.40

What happened

INVE Technologies, Inc., a Santa Ana, California-based company listed under the ticker INVE and classified in SEC records as a maker of computer peripheral equipment, filed a Tender Offer Statement on Schedule TO with the Securities and Exchange Commission on October 21, 2026.

The filing sets out an offer by the company to buy back up to $20 million in value of its common stock, $0.001 par value, in cash. Shareholders may tender shares at a price they choose within a range of $2.85 to $3.40 per share. The offer is documented in an Offer to Purchase and a related Letter of Transmittal, both dated October 21, 2026.

The filing states the transaction is an issuer tender offer under Rule 13e-4 and relies on Rule 13e-4(c)(2) to satisfy its reporting obligations. It checks the box for an issuer tender offer, not a third-party offer or a going-private transaction.

The price moves

INVE closed at $2.78 on the event date, up 25.23% from the prior close of $2.22, according to the price data. Volume was 15,271,273 shares, about 83 times the average volume of 183,522.

The offer's range sits above the closing price: the bottom of $2.85 is $0.07 above the $2.78 close, and the top of $3.40 is $0.62 above it. The filing does not state a reason for the stock move or the volume.

What this means

A Schedule TO is the cover document a company or outside bidder must file with the SEC when it launches a tender offer for a class of securities. Because the offeror here is the company itself buying its own shares, it is an issuer tender offer under Rule 13e-4. The rule requires the company to file the statement on the day the offer begins and to disclose the terms, the source of funds, and any arrangements with directors and officers.

The structure described is a modified Dutch auction. Rather than set one fixed price, the company names a range — here $2.85 to $3.40 — and shareholders say how many shares they will sell and at what price inside that range. The company then picks a single clearing price, within the range, that lets it buy up to $20 million in value. Shareholders who ask for more than the clearing price are not bought out; those who ask at or below it are, and if the offer is oversubscribed, purchases are prorated. That is the "Number of Shares; Proration" section referenced in Item 4 of the filing.

The total is capped by dollar value rather than share count: at $3.40, $20 million would buy roughly 5.9 million shares; at $2.85, roughly 7.0 million. The actual number depends on the clearing price.

The filing states there are no conditions to the offer and no borrowed funds; the source of funds is addressed in Section 8 of the Offer to Purchase, which the Schedule TO incorporates by reference. No material legal proceedings relating to the offer are pending, according to the company.

The filing does not explain why INVE is running the offer. Its purpose section is incorporated by reference to the Offer to Purchase rather than restated in the Schedule TO, and the press release announcing the offer is listed as an exhibit rather than reproduced.

What comes next

The Offer to Purchase and Letter of Transmittal — the documents shareholders actually use to tender — are filed as exhibits to the Schedule TO. The expiration date, withdrawal rights, and settlement timing are set out in those exhibits and in Sections 4, 5 and 13 of the Offer to Purchase, which the filing references but does not restate. A separate Schedule TO-C carrying the company's press release was filed the same day.

The filing gives no timetable beyond the offer date of October 21, 2026.